Lymphatic filariasis elimination endgame in an urban Indian setting: the roles of surveillance and residual microfilaremia after mass drug administration

被引:4
|
作者
Modi, Anjali [1 ]
Vaishnav, Keshav G. [2 ]
Kothiya, Kailash [2 ]
Alexander, Neal [3 ]
机构
[1] Govt Med Coll, Dept Community Med, Surat, Gujarat, India
[2] Surat Municipal Corp, Vector Borne Dis Control VBDC Dept, Surat, Gujarat, India
[3] London Sch Hyg & Trop Med, MRC Int Stat & Epidemiol Grp, London, England
关键词
Lymphatic filariasis; Urban; Migration; Mass drug administration; Surveillance; Epidemiological; Elimination; Residual microfilaremia; MIGRATION;
D O I
10.1186/s40249-021-00856-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: To secure the gains of lymphatic filariasis (LF) elimination programs, attention is needed to the `residual microfilaremia phase', in which high-risk populations may be crucial. The present study documents the impact of mass drug administration (MDA) in the urban Indian setting of Surat City, with high rates of in-migration. Methods: Epidemiological assessment included National Filaria Control Program (NFCP) and World Health Organization recommended routine and pre-MDA microfilaremia surveys respectively. Routine filaria surveys were conducted around the year in approximately 2000-4000 people per month, while pre-MDA surveys were carried out annually among approximately 4000 people from four fixed and four random sites. In 2016, Transmission Assessment Survey (TAS) was done in primary school children. The outcomes were microfilaremia (Mf) and antigen prevalence; more specifically, microfilaremia according to place of birth, in pre-MDA and routine night blood smears (NBS) collected from 2008 to 2015. Prevalence ratios and confidence intervals were calculated. Results: A total of 25 480 pre-MDA and 306 198 routine NBS were examined during the study. In 2008, the Mf prevalence in the routine survey was 63/18 814 (0.33%), declining to 23/39 717 (0.06%) in 2016. Pre-MDA surveys showed a similar decrease from 47/4184 (1.1%) in 2008 to 12/4042 (0.3%) in 2015. In those born outside Surat, microfilaremia decreased below transmission thresholds, but remained more than treble that of the remainder of the population, in both the pre-MDA surveys [prevalence ratio: 3.17, 95% confidence interval (CI): 1.15-8.72], and the routine surveys (3.31, 95% CI: 1.47-7.48). Though the TAS results indicated that MDA endpoints had been reached, sub-group analysis identified that 90% of antigenemic children were from families of high-risk groups. Conclusions: Extensive long-term epidemiological monitoring suggests that all the urban population, including high-risk groups, have benefitted from the ELF program. To prevent re- establishment of infection in large urban areas with unsanitary conditions conducive to filarial vector breeding, there is need to identify residual microfilaremia by customized surveys in addition to pre-MDA monitoring and TAS. The present findings can be used to develop strategies to prioritize screening, surveillance and plan treatment of high-risk groups after achieving MDA endpoints.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Lymphatic filariasis elimination endgame in an urban Indian setting: the roles of surveillance and residual microfilaremia after mass drug administration
    Anjali Modi
    Keshav G. Vaishnav
    Kailash Kothiya
    Neal Alexander
    [J]. Infectious Diseases of Poverty, 10
  • [2] LESSONS FROM MASS DRUG ADMINISTRATION FOR THE ELIMINATION OF LYMPHATIC FILARIASIS (LF) IN AN URBAN SETTING IN HAITI
    Bennett, Cudjoe
    Fayette, Carl
    Monestime, Franck
    Javel, Alain
    Miller, Lior
    Craciunoiu, Sarah
    Direny, Abdel
    Lemoine, Jean-Franze
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 155 - 155
  • [3] Increasing Coverage in Mass Drug Administration for Lymphatic Filariasis Elimination in an Urban Setting: a Study of Malindi Town, Kenya
    Njomo, Doris W.
    Mukoko, Dunstan A.
    Nyamongo, Nipher K.
    Karanja, Joan
    [J]. PLOS ONE, 2014, 9 (01):
  • [4] No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds
    Yaya Ibrahim Coulibaly
    Moussa Sangare
    Housseini Dolo
    Lamine Soumaoro
    Siaka Yamoussa Coulibaly
    Ilo Dicko
    Abdoul Fatao Diabaté
    Lamine Diarra
    Michel Emmanuel Coulibaly
    Salif Seriba Doumbia
    Abdallah Amadou Diallo
    Massitan Dembele
    Benjamin G. Koudou
    Moses John Bockarie
    Louise A. Kelly-Hope
    Amy D. Klion
    Thomas B. Nutman
    [J]. Parasitology Research, 2022, 121 : 3243 - 3248
  • [5] Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu
    Taleo F.
    Taleo G.
    Graves P.M.
    Wood P.
    Kim S.H.
    Ozaki M.
    Joseph H.
    Chu B.
    Pavluck A.
    Yajima A.
    Melrose W.
    Ichimori K.
    Capuano C.
    [J]. Tropical Medicine and Health, 45 (1)
  • [6] No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds
    Coulibaly, Yaya Ibrahim
    Sangare, Moussa
    Dolo, Housseini
    Soumaoro, Lamine
    Coulibaly, Siaka Yamoussa
    Dicko, Ilo
    Diabate, Abdoul Fatao
    Diarra, Lamine
    Coulibaly, Michel Emmanuel
    Doumbia, Salif Seriba
    Diallo, Abdallah Amadou
    Dembele, Massitan
    Koudou, Benjamin G.
    Bockarie, Moses John
    Kelly-Hope, Louise A.
    Klion, Amy D.
    Nutman, Thomas B.
    [J]. PARASITOLOGY RESEARCH, 2022, 121 (11) : 3243 - 3248
  • [7] National Mass Drug Administration Costs for Lymphatic Filariasis Elimination
    Goldman, Ann S.
    Guisinger, Victoria H.
    Aikins, Moses
    Amarillo, Maria Lourdes E.
    Belizario, Vicente Y.
    Garshong, Bertha
    Gyapong, John
    Kabali, Conrad
    Kamal, Hussein A.
    Kanjilal, Sanjat
    Kyelem, Dominique
    Lizardo, Jefrey
    Malecela, Mwele
    Mubyazi, Godfrey
    Nitiema, P. Abdoulaye
    Ramzy, Reda M. R.
    Streit, Thomas G.
    Wallace, Aaron
    Brady, Molly A.
    Rheingans, Richard
    Ottesen, Eric A.
    Haddix, Anne C.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2007, 1 (01):
  • [8] Impact of mass drug administration for elimination of lymphatic filariasis in Nepal
    Ojha, Chet Raj
    Joshi, Basant
    Prakash, Khagendra K. C.
    Dumre, Shyam Prakash
    Yogi, Keshav Kumar
    Bhatta, Bandana
    Adhikari, Tulasi
    Crowley, Kathryn
    Marasini, Babu Ram
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (07):
  • [9] Mass drug administration for elimination of lymphatic filariasis: a discussion reply
    Karmakar, Prasanta Ray
    [J]. JOURNAL OF VECTOR BORNE DISEASES, 2011, 48 (03) : 182 - 182
  • [10] Elimination of lymphatic filariasis: current perspectives on mass drug administration
    Gyapong, John O.
    Owusu, Irene O.
    Vroom, Frances B. da-Costa
    Mensah, Ernest O.
    Gyapong, Margaret
    [J]. RESEARCH AND REPORTS IN TROPICAL MEDICINE, 2018, 9 : 25 - 33